Skip to content
WorldBrand.AI
HomeAboutBrand WikiAEOWorld ModelComing SoonBlog
WorldBrand.AI

The intelligence platform for brands in the AI era.

Products
  • AEO Intelligence
  • Brand Wiki
  • World Model
  • Enterprise
Company
  • About
  • Blog
  • Pricing
Brand Wiki
  • About Brand Wiki
  • Methodology
  • Sources
  • Editorial policy
  • API

© 2026 WorldBrand.ai. All rights reserved.

Privacy PolicyTerms of Use

Similac/Controversies

Similac controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile

  1. 2022Sturgis powdered-formula recall and shortage
  2. Necrotizing-enterocolitis litigation

  1. 2022

    Sturgis powdered-formula recall and shortage

    Abbott recalled specified lots of powdered Similac and other formulas made at its Sturgis, Michigan, plant after reports of infant illnesses and regulatory concerns about possible Cronobacter contamination and plant conditions. The shutdown contributed to a severe U.S. infant-formula shortage. The recall concerned specified products and lots, not necessarily every Similac product.

    Source

  2. Necrotizing-enterocolitis litigation

    Lawsuits brought by families of premature infants have alleged that Abbott’s marketing and warnings did not adequately communicate claimed risks associated with cow’s-milk-based formulas or fortifiers and NEC. The allegations are contested and case outcomes vary.

    Source